| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa97fb03745e1bbb6828203a83d4d8ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96e1bced372ca18c832f733eac7bed7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0d41b83d0f4fbd7aa1fd71f4b3f92de |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2014-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6621aa3c8842e7b29bf0a7db2edcdeec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec4575e27ba27b38853503bf994d74f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_483d4ace62bdf3a96b70edee01fad641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa7b0debeedb2c049ca1e76984c446b |
| publicationDate |
2016-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3071972-A2 |
| titleOfInvention |
Method for in vitro diagnosing and prognosing of triple negative breast cancer recurrence |
| abstract |
The present invention is in the technical field of breast cancer management, and more particularly relates to the diagnosis and/or prognosing of triple-negative breast cancer (TNBC). The invention is more particularly based on the finding that specific biomarkers are abberantly expressed in patients suffering from a triple-negative breast cancer recurrence, and are highly related to the aggressiveness of this disease, and thus to survival of said patient. |
| priorityDate |
2013-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |